Results 81 to 90 of about 4,105,314 (99)

Combined Nabpaclitaxel pressurized intraPeritoneal aerosol chemotherapy with systemic Nabpaclitaxel-Gemcitabine chemotherapy for pancreatic cancer peritoneal metastases: protocol of single-arm, open-label, phase II trial (Nab-PIPAC trial). [PDF]

Pleura Peritoneum
Di Giorgio A, Ferracci F, Bagalà C, Carbone C, Salvatore L, Strippoli A, Attalla El Halabieh M, Abatini C, Alfieri S, Pacelli F, Tortora G.   +10 more
europepmc   +1 more source

Pressurized Intraperitoneal Aerosol Chemotherapy for Peritoneal Carcinomatosis in Colorectal Cancer Patients: A Systematic Review of the Evidence. [PDF]

Cancers (Basel)
Sleiman MJ, Jelip A, Buchs N, Toso C, Liot E, Koessler T, Meyer J, Meurette G, Ris F.   +8 more
europepmc   +1 more source

Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) for Gastric Cancer Peritoneal Metastases: Results from the Lithuanian PIPAC Program. [PDF]

Cancers (Basel)
Luksta M, Bausys A, Gendvilaite N, Bickaite K, Rackauskas R, Paskonis M, Luksaite-Lukste R, Ranceva A, Stulpinas R, Brasiuniene B, Baltruskeviciene E, Lachej N, Bausiene J, Poskus T, Bausys R, Tulyte S, Strupas K.   +16 more
europepmc   +1 more source

Pressurized intraperitoneal aerosol chemotherapy in advanced gastric cancer with peritoneal metastases: a comprehensive meta-analysis of feasibility, efficacy, and safety. [PDF]

Gastroenterol Rep (Oxf)
Chen R, Yang Z, Li R, Yang Y, Zheng J, Wang J, Li Y.   +6 more
europepmc   +1 more source

Multicenter dose de-escalation phase I trial of pressurized intraperitoneal aerosolized chemotherapy (PIPAC) nab-paclitaxel and cisplatin in combination with systemic nab-paclitaxel in recurrent ovarian cancer patients: trial in progress. [PDF]

Pleura Peritoneum
Popat V, Frankel PH, Ruel NH, Yost SE, Chang S, Wang E, Villella J, Whyte J, Whelan RL, Eng M, Tinsley R, Synold T, Han E, Song M, Cohen J, Raoof M, Dellinger TH.   +16 more
europepmc   +1 more source

Regional Therapies Utilized in Treating Unresectable Colorectal Adenocarcinoma with Peritoneal Metastases. [PDF]

Cancers (Basel)
Malik S, Le V, Dayyani F, Senthil M, Eng OS, O'Leary MP.   +5 more
europepmc   +1 more source

Safety of pressurized intraperitoneal aerosolized chemotherapy in biliary cancer patients with peritoneal metastases. [PDF]

Future Oncol
Li D, Crook C, Chung V, Brar G, Fakih M, Barzi A, Melstrom L, Singh G, Fong Y, Frankel P, Raoof M.   +10 more
europepmc   +1 more source

Role of Immunohistochemistry for Interobserver Agreement of Peritoneal Regression Grading Score in Peritoneal Metastasis [PDF]

Human Pathology, 2022
Pressurized intraperitoneal aerosol chemotherapy (PIPAC)–directed therapy is a new treatment option for peritoneal metastasis (PM). The 4-tiered Peritoneal Regression Grading Score (PRGS) has been proposed for assessment of histological treatment ...
Martin Graversen, Daniel Neureiter, Norman J Carr   +2 more
exaly   +2 more sources

Prognostic Impact of Combined Progression Index Based on Peritoneal Grading Regression Score and Peritoneal Cytology in Peritoneal Metastasis

Histopathology, 2020
International audienceAims The peritoneal regression grading score (PRGS) and peritoneal cytology (PC) assess response to chemotherapy in peritoneal metastasis (PM) in a setting of palliative treatment by pressurized intraperitoneal aerosol chemotherapy (
Mohammad Alyami, Olivier Glehen, Nazim Benzerdjeb   +2 more
exaly   +2 more sources

Reproducibility of the Peritoneal Regression Grading Score for Assessment of Response to Therapy in Peritoneal Metastasis [PDF]

Histopathology, 2019
Aims: The four-tiered peritoneal regression grading score (PRGS) assesses the response to chemotherapy in peritoneal metastasis (PM). The PRGS is used, for example, to assess the response to pressurised intraperitoneal aerosol chemotherapy (PIPAC ...
Daniel Neureiter, Tarkan Jäger, Norman J Carr   +2 more
exaly   +2 more sources